Argyle Capital Management, LLC / MDT
Argyle Capital Management, LLC’s Medtronic PLC Position
Does Argyle Capital Management, LLC own Medtronic PLC (MDT)? Yes — 38.1K shares worth $3M (+1.07% of its 13F portfolio) as of Q1 2026, up from 37.3K shares the prior filed quarter.
Position Value
$3M
Q1 2026
Shares
38.1K
% of Portfolio
+1.07%
Quarters Held
18
currently held
Position History MDT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 38.1K | $3M | +1.07% |
| Q4 2025 | 37.3K | $4M | +1.20% |
| Q3 2025 | 37.1K | $4M | +1.22% |
| Q2 2025 | 37.1K | $3M | +1.17% |
| Q1 2025 | 36.9K | $3M | +1.23% |
| Q4 2024 | 36.7K | $3M | +1.15% |
| Q3 2024 | 34.0K | $3M | +1.22% |
| Q2 2024 | 36.3K | $3M | +1.18% |
| Q1 2024 | 37.9K | $3M | +1.28% |
| Q4 2023 | 39.9K | $3M | +1.36% |
| Q3 2023 | 47.4K | $4M | +1.36% |
| Q2 2023 | 45.9K | $4M | +1.46% |
| Q1 2023 | 46.5K | $4M | +1.32% |
| Q4 2022 | 42.6K | $3M | +1.14% |
| Q3 2022 | 42.6K | $3M | +1.34% |
| Q2 2022 | 41.8K | $4M | +1.35% |
| Q1 2022 | 41.4K | $5M | +1.49% |
| Q4 2021 | 43.5K | $5M | +1.40% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Argyle Capital Management, LLC’s full portfolio or all institutional holders of MDT.